The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

The dermatomyositis market is expected to witness steady growth over the next decade, driven by increasing awareness, improved diagnostic tools, and advancements in treatment options. The rising ...

Migraine sufferers find relief with new treatment options by: Jakob Butler, Gretchen Bolander Posted: Jun 19, 2025 / 04:56 PM CDT Updated: Jun 20, 2025 / 09:30 AM CDT ...

The dermatomyositis market is expected to witness steady growth over the next decade, driven by increasing awareness, improved diagnostic tools, and advancements in treatment options. The rising ...

The dermatomyositis market is expected to witness steady growth over the next decade, driven by increasing awareness, improved diagnostic tools, and advancements in treatment options. The rising ...

Objective Complete congenital heart block (CHB) due to anti-Ro/La antibodies in pregnancy can lead to adverse fetal outcomes and neonatal death. National and international guidelines do not recommend ...

EP: 11. Other Investigational Treatment Options for SMA EP: 12. Insurance Considerations for SMA Therapies EP: 13. Optimizing Multidisciplinary Care Approaches for the Future of SMA Management EP: 14.

Kathy Newt Access to new treatments shouldn’t depend on where you live. But in Montana, where distance, insurance networks, and availability already limit options, Washington’s latest drug pricing ...

Lung cancer is a disease that now has various therapeutic options available, especially following data read outs at the 2025 ASCO Annual Meeting, according to Dr. Joshua K. Sabari and Dr. Prantesh ...

DelveInsight’s “ Dermatomyositis Market Insight, Epidemiology, and Market Forecast – 2034 ” provides an in-depth analysis of the current landscape and future outlook of the DM market across major ...